Literature DB >> 566644

Antibodies to lactalbumin interfere with its radioimmunoassay in human plasma.

U Stevens, D J Laurence, M G Ormerod.   

Abstract

Two radioimmunoassays for human lactalbumin have been established using a rabbit antiserum. One assay uses a second antibody to separate bound from free label; the other uses polyethylene glycol to precipitate gamma globulin non-specifically. We have confirmed that about half the normal human population have a substance in their blood which inhibits the binding of lactalbumin to the rabbit antibody. Comparison of the two assays has demonstrated that this material is not lactalbumin but a naturally occurring antibody. We have shown that it is in the IgG fraction of human plasma and is probably a cross-reacting antibody to bovine lactalbumin. None out of fifteen males and fourteen out of fifty eight non-pregnant, non-lactating females had low levels of lactalbumin in the their blood (0.6--2.0 ng/ml). Our assay could not detect a statistically significant difference between normal women and those with either benign breast disease or metastatic mammary carcinoma.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 566644     DOI: 10.1016/0009-8981(78)90069-4

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

1.  The construction, identification and characterisation of plasmids containing human alpha-lactalbumin cDNA sequences.

Authors:  L Hall; M S Davies; R K Craig
Journal:  Nucleic Acids Res       Date:  1981-01-10       Impact factor: 16.971

Review 2.  Stem cells and the development of mammary cancers in experimental rats and in humans.

Authors:  P S Rudland
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

3.  Comparative functional histopathology of human breast carcinoma xenografts.

Authors:  M J Bailey; M G Ormerod; S F Imrie; J Humphreys; J D Roberts; J C Gazet; A M Neville
Journal:  Br J Cancer       Date:  1981-02       Impact factor: 7.640

4.  Ability of CEA blood levels to reflect tumour burden: a study in a human xenograft model.

Authors:  J B Quayle
Journal:  Br J Cancer       Date:  1982-08       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.